Literature DB >> 26679283

Traceability in stem cell research: from participant sample to induced pluripotent stem cell and back.

Michael Morrison1, Linda Briceño Moraia1, Jane C Steele2.   

Abstract

This paper describes a traceability system developed for the Stem cells for Biological Assays of Novel drugs and prediCtive toxiCology consortium. The system combines records and labels that to biological material across geographical locations and scientific processes from sample donation to induced pluripotent stem cell line. The labeling system uses a unique identification number to link every aliquot of sample at every stage of the reprogramming pathway back to the original donor. Only staff at the clinical recruitment site can reconnect the unique identification number to the identifying details of a specific donor. This ensures the system meets ethical and legal requirements for protecting privacy while allowing full traceability of biological material. The system can be adapted to other projects and for use with different primary sample types.

Entities:  

Keywords:  biobanking; induced pluripotent stem cells; innovative medicines initiative; legal requirements; privacy; research collaboration; tissues and cells directive; traceability

Mesh:

Year:  2015        PMID: 26679283     DOI: 10.2217/rme.15.66

Source DB:  PubMed          Journal:  Regen Med        ISSN: 1746-0751            Impact factor:   3.806


  1 in total

1.  The European General Data Protection Regulation: challenges and considerations for iPSC researchers and biobanks.

Authors:  Michael Morrison; Jessica Bell; Carol George; Shawn Harmon; Megan Munsie; Jane Kaye
Journal:  Regen Med       Date:  2017-10-04       Impact factor: 3.806

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.